My take on Lilly increasing its UK mounjaro price is that the company is buying some goodwill for the US administration. As you stated, it has no impact on the NHS price and represents only a sliver of the UK market in volume terms (which is itself pretty small). A sign of things to come though
My take on Lilly increasing its UK mounjaro price is that the company is buying some goodwill for the US administration. As you stated, it has no impact on the NHS price and represents only a sliver of the UK market in volume terms (which is itself pretty small). A sign of things to come though